Showing results (171-180 of 775) with videos related to

Sort By:
Pageof 78
JACC. Cardiovascular Interventions|May 26, 2009
First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trialCorrado Tamburino, Alessio La Manna, Maria Elena Di Salvo, et al.
European Heart Journal|August 31, 2016
Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney diseaseUsman Baber, Michael E Farkouh, Yaron Arbel, et al.
The American Journal of Cardiology|December 26, 2015
Meta-Analysis of Radial Versus Femoral Access for Percutaneous Coronary Interventions in Non-ST-Segment Elevation Acute Coronary SyndromeChirag Bavishi, Sadik R Panwar, George D Dangas, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 12, 2018
Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantationsLi Song, Changdong Guan, Hongbing Yan, et al.
The American Journal of Cardiology|November 12, 2003
Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapyCostantino O Costantini, Alexandra J Lansky, Gary S Mintz, et al.
Journal of Interventional Cardiology|February 18, 2015
Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trialJason C Kovacic, Annapoorna Kini, Subhash Banerjee, et al.
JAMA Cardiology|December 23, 2024
Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A ReviewAnton Camaj, Pier Pasquale Leone, Antonio Colombo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2020
Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGYUsman Baber, Rishi Chandiramani, Shamir R Mehta, et al.
The American Journal of Cardiology|November 2, 2013
Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial)Adriano Caixeta, Philippe Généreux, Tullio Palmerini, et al.
Journal of the American College of Cardiology|February 15, 2015
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trialsGennaro Giustino, Usman Baber, Samantha Sartori, et al.
Pageof 78